These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30954437)

  • 21. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.
    Hirohata M; Ono K; Yamada M
    Curr Pharm Des; 2008; 14(30):3280-94. PubMed ID: 19075706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
    van Groen T; Kadish I
    Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and Alzheimer's disease.
    Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
    Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of non-steroidal anti-inflammatory drugs in treating Alzheimer's disease.
    Imbimbo BP
    Expert Opin Investig Drugs; 2004 Nov; 13(11):1469-81. PubMed ID: 15500394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.
    Prasad KN; Cole WC; Prasad KC
    J Am Coll Nutr; 2002 Dec; 21(6):506-22. PubMed ID: 12480796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of NMDAR2B in an inflammatory model of Alzheimer's disease: modulation by NOS inhibitors.
    Maher A; El-Sayed NS; Breitinger HG; Gad MZ
    Brain Res Bull; 2014 Oct; 109():109-16. PubMed ID: 25454121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer's disease.
    Maione F; Piccolo M; De Vita S; Chini MG; Cristiano C; De Caro C; Lippiello P; Miniaci MC; Santamaria R; Irace C; De Feo V; Calignano A; Mascolo N; Bifulco G
    Pharmacol Res; 2018 Mar; 129():482-490. PubMed ID: 29158049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.
    Deardorff WJ; Grossberg GT
    Expert Rev Neurother; 2017 Jan; 17(1):17-32. PubMed ID: 27293026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
    Dong Y; Li X; Cheng J; Hou L
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease].
    Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
    Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated astroglia during chronic inflammation in Alzheimer's disease--do they neglect their neurosupportive roles?
    Fuller S; Steele M; Münch G
    Mutat Res; 2010 Aug; 690(1-2):40-9. PubMed ID: 19748514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NGA- A Novel Hypothetical Drug Model: Combinatorial Approach to Multifactorial Alzheimer's Disease.
    Devi CS; Mohanasrinivasan V; Priyadoss CG; Arora N; Singh B; Mittal N; Agarwal S; Saxena S
    Curr Drug Discov Technol; 2015; 12(4):214-7. PubMed ID: 26572486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications.
    Di Bona D; Scapagnini G; Candore G; Castiglia L; Colonna-Romano G; Duro G; Nuzzo D; Iemolo F; Lio D; Pellicanò M; Scafidi V; Caruso C; Vasto S
    Curr Pharm Des; 2010; 16(6):684-91. PubMed ID: 20388078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation, genes and zinc in Alzheimer's disease.
    Vasto S; Candore G; Listì F; Balistreri CR; Colonna-Romano G; Malavolta M; Lio D; Nuzzo D; Mocchegiani E; Di Bona D; Caruso C
    Brain Res Rev; 2008 Jun; 58(1):96-105. PubMed ID: 18190968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of cyclooxygenases in neurotoxicity of amyloid beta peptides in Alzheimer's disease].
    Cakała M; Strosznajder JB
    Neurol Neurochir Pol; 2010; 44(1):65-79. PubMed ID: 20358486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.